FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 269 of 269

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TYRA Nasdaq Tyra Biosciences, Inc. 2830
UPB Nasdaq Upstream Bio, Inc. 2830
UTHR Nasdaq United Therapeutics Corporation 2830
VBIO Nasdaq Valion Bio, Inc. 2830
VFF Nasdaq Village Farms International, Inc. 2830
VIR Nasdaq Vir Biotechnology, Inc. 2830
VKTX Nasdaq Viking Therapeutics, Inc. 2830
VRDN Nasdaq Viridian Therapeutics, Inc. 2830
VRNO Over the counter Verano Holdings Corp. 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VTVT Nasdaq vTv Therapeutics Inc. 2830
WVE Nasdaq Wave Life Sciences Ltd. 2830
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2830
XRTX Nasdaq XORTX Therapeutics Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZTEK Nasdaq Zentek Ltd. 2830
ZURA Nasdaq Zura Bio Limited 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 269 of 269